Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

12 results
Display

The effects of direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute exacerbation of interstitial lung disease

Lee JH, Park JH, Kim HJ, Kim HK, Jang JH, Kim YK, Park BS, Park SH, Kim IH, Kim SH, Heo W, Jang HJ

Background: Acute exacerbation of interstitial lung disease (AE-ILD) causes clinically significant deterioration and has an extremely poor prognosis with high mortality. Recently, several studies reported the effectiveness of direct hemoperfusion...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock

Mitaka C, Kusaoi M, Kawagoe I, Satoh D

Endotoxin adsorption therapy by polymyxin B-immobilized fiber column direct hemoperfusion (PMX-DHP) has been used for the treatment of septic shock patients. Endotoxin, an outer membrane component of Gram-negative bacteria, plays...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Initial Experience of Using Polymyxin B Hemoperfusion in Abdominal Septic Shock: Things to Consider for Better Outcome

Park YJ, Kim EY

Purpose: Polymyxin B hemoperfusion (which treats septic shock by removing endotoxins of gram-negative bacteria), has been proposed as a treatment modality for intraabdominal sepsis. However, there are few studies about...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Direct hemoperfusion with polymyxin B-immobilized fiber column in a patient with acute exacerbation of idiopathic pulmonary fibrosis

Kim SY, Park JH, Kim HJ, Jang HJ, Kim HK, Kim SH, Lee JH

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterized by dyspnea and a worsening of the lung function. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are defined...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A successful application of adult polymyxin B-immobilized fiber column hemoperfusion to a neonate with septic shock

Kim YA, Kim H, Kim YM, Park SE

Direct hemoperfusion therapy with a polymyxin B-immobilized fiber column (PMX-HP) has been introduced as a therapeutic option for gram negative bacterial septic shock in adults. However, its use in neonates...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Polymyxin B Hemoperfusion in a Patient with Septic Shock and Septic Cardiomyopathy Who Was Placed on Extracorporeal Membrane Oxygen Support

Shin SH, Lee H, Choi AJ, Chang KH, Suh GY, Chung CR

Although shock in sepsis is usually managed successfully by conventional medical treatment, a subset of cases do not respond and may require salvage therapies such as veno-arterial extracorporeal membrane oxygenation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Refractory Septic Shock Treated with Nephrectomy under the Support of Extracorporeal Membrane Oxygenation

Lee YK, Ryu JA, Yang JH, Park CM, Suh GY, Jeon K, Chung CR

Conventional medical therapies have not been very successful in treating adults with refractory septic shock. The effects of direct hemoperfusion using polymyxin B and veno-arterial extracorporeal membrane oxygenation (ECMO) for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Polymyxin B Hemoperfusion in Pneumonic Septic Shock Caused by Gram-Negative Bacteria

Yoo JW, Park SY, Jeon J, Huh JW, Lim CM, Koh Y, Hong SB

Severe sepsis and septic shock are the main causes of death in critically ill patients. Early detection and appropriate treatment according to guidelines are crucial for achieving favorable outcomes. Endotoxin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Polymyxin B Immobilized Fiber Hemoperfusion in Refractory Intra-abdominal Septic Shock

Chang HW, Cho YJ, Park SH, Kim M

The effects of direct hemoperfusion with polymyxin B immobilized fiber (PMX) treatment for septic shock have been recently reported. However, little evidence of a true benefit on clinical outcomes, including...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Susceptibility of Clinical Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa to Colistin and Polymyxin B in Korea

Song W, Lee TJ, Park MJ, Kim HS, Kim JS, Woo HJ, Lee KM

  • KMID: 2285066
  • Infect Chemother.
  • 2006 Dec;38(6):362-366.
BACKGROUND: The emergence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa has become a major problem. The use of nontraditional agents such as colistin and polymyxin B have been tried. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mutant Prevention Concentration of Polymyxin B for the Clinical Isolates of Pseudomonas aeruginosa

Choi CU, Seo MR, Lim YH, Pai H

  • KMID: 2285063
  • Infect Chemother.
  • 2006 Dec;38(6):344-348.
BACKGROUND: Infection caused by multi-drug resistant (MDR) Gram-negative organisms such as Pseudomonas and Acinetobacter species is one of emerging important problems in modern hospitals. To treat multi-drug resistant non-fermenting Gram-negatives,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Study on the Role of Protein Kinase C upon the Acetylcholine Release in the Rat Hippocampus

Kim JS, Kang SD, Kim JM, Choi BK

  • KMID: 2187883
  • J Korean Neurosurg Soc.
  • 1995 Feb;24(2):115-122.
The effects and interactions of 4 beta-phorbol 12,13-dibutyrate(PDB) and polymyxin B(PMB) with adenosine on the electrically-evoked acetylcholine(ACh) release were studied in rat hippocampus. Slices from rat hippocampus were equilibrated with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr